Report Detail
Global Lerociclib Hydrochloride Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4706229 |
- 09 June, 2026 |
- Global |
- 77 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Lerociclib Hydrochloride Tablets market size was valued at US$ 59.68 million in 2025 and is forecast to a readjusted size of US$ 318 million by 2032 with a CAGR of 18.5% during review period.
Lerociclib Hydrochloride Tablets are an orally administered small-molecule cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, primarily used for the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. The drug selectively inhibits CDK4 and CDK6 activity, blocking the progression of the cell cycle from the G1 phase to the S phase, thereby suppressing tumor cell proliferation and delaying disease progression. As a next-generation CDK4/6 inhibitor, lerociclib demonstrates potential advantages in continuous dosing regimens and safety, and is suitable for use in combination with endocrine therapy to enhance antitumor efficacy. The drug has entered clinical application and is being gradually adopted in the treatment of breast cancer.In 2025, global lerociclib hydrochloride tablets 盐酸来罗西利片， production reached approximately 60,000–80,000 bottles
Lerociclib Hydrochloride Tablets, as a next-generation CDK4/6 inhibitor, are positioned within the rapidly growing targeted therapy market for breast cancer and demonstrate solid growth potential. In recent years, driven by the increasing incidence of breast cancer and the widespread adoption of precision medicine and endocrine combination therapies, the global CDK4/6 inhibitor market has reached a multi-billion-dollar scale, primarily dominated by established products such as palbociclib, abemaciclib, and ribociclib. In this context, lerociclib has the potential to achieve differentiated competition in certain patient populations due to its continuous dosing design and potential safety advantages. However, given the highly concentrated market landscape, new entrants face significant barriers to market access and intense competitive pressure. Its commercialization progress will therefore depend on clinical data validation, reimbursement coverage, and marketing capabilities. Consequently, future market performance will largely rely on indication expansion, combination therapy strategies, and the advancement of global market deployment.
This report is a detailed and comprehensive analysis for global Lerociclib Hydrochloride Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Lerociclib Hydrochloride Tablets market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Lerociclib Hydrochloride Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Lerociclib Hydrochloride Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Lerociclib Hydrochloride Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lerociclib Hydrochloride Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Lerociclib Hydrochloride Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Genor Biopharma, G1 Therapeutics, Quotient Sciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Lerociclib Hydrochloride Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
With Aromatase Inhibitors in Combination Therapy
With Fulvestrant in Combination Therapy
Market segment by Specification
50 mg tablets
150 mg tablets
Market segment by Sales Channels
Hospital
Retail
Online
Market segment by Production Technology
Originator
Generic
Market segment by Application
Advanced breast cancer
Metastatic breast cancer
Others
Major players covered
Genor Biopharma
G1 Therapeutics
Quotient Sciences
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lerociclib Hydrochloride Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Lerociclib Hydrochloride Tablets, with price, sales quantity, revenue, and global market share of Lerociclib Hydrochloride Tablets from 2021 to 2026.
Chapter 3, the Lerociclib Hydrochloride Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lerociclib Hydrochloride Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Lerociclib Hydrochloride Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Lerociclib Hydrochloride Tablets.
Chapter 14 and 15, to describe Lerociclib Hydrochloride Tablets sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Lerociclib Hydrochloride Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 With Aromatase Inhibitors in Combination Therapy
- 1.3.3 With Fulvestrant in Combination Therapy
- 1.4 Market Analysis by Specification
- 1.4.1 Overview: Global Lerociclib Hydrochloride Tablets Consumption Value by Specification: 2021 Versus 2025 Versus 2032
- 1.4.2 50 mg tablets
- 1.4.3 150 mg tablets
- 1.5 Market Analysis by Sales Channels
- 1.5.1 Overview: Global Lerociclib Hydrochloride Tablets Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
- 1.5.2 Hospital
- 1.5.3 Retail
- 1.5.4 Online
- 1.6 Market Analysis by Production Technology
- 1.6.1 Overview: Global Lerociclib Hydrochloride Tablets Consumption Value by Production Technology: 2021 Versus 2025 Versus 2032
- 1.6.2 Originator
- 1.6.3 Generic
- 1.7 Market Analysis by Application
- 1.7.1 Overview: Global Lerociclib Hydrochloride Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.7.2 Advanced breast cancer
- 1.7.3 Metastatic breast cancer
- 1.7.4 Others
- 1.8 Global Lerociclib Hydrochloride Tablets Market Size & Forecast
- 1.8.1 Global Lerociclib Hydrochloride Tablets Consumption Value (2021 & 2025 & 2032)
- 1.8.2 Global Lerociclib Hydrochloride Tablets Sales Quantity (2021-2032)
- 1.8.3 Global Lerociclib Hydrochloride Tablets Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Genor Biopharma
- 2.1.1 Genor Biopharma Details
- 2.1.2 Genor Biopharma Major Business
- 2.1.3 Genor Biopharma Lerociclib Hydrochloride Tablets Product and Services
- 2.1.4 Genor Biopharma Lerociclib Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Genor Biopharma Recent Developments/Updates
- 2.2 G1 Therapeutics
- 2.2.1 G1 Therapeutics Details
- 2.2.2 G1 Therapeutics Major Business
- 2.2.3 G1 Therapeutics Lerociclib Hydrochloride Tablets Product and Services
- 2.2.4 G1 Therapeutics Lerociclib Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 G1 Therapeutics Recent Developments/Updates
- 2.3 Quotient Sciences
- 2.3.1 Quotient Sciences Details
- 2.3.2 Quotient Sciences Major Business
- 2.3.3 Quotient Sciences Lerociclib Hydrochloride Tablets Product and Services
- 2.3.4 Quotient Sciences Lerociclib Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Quotient Sciences Recent Developments/Updates
3 Competitive Environment: Lerociclib Hydrochloride Tablets by Manufacturer
- 3.1 Global Lerociclib Hydrochloride Tablets Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Lerociclib Hydrochloride Tablets Revenue by Manufacturer (2021-2026)
- 3.3 Global Lerociclib Hydrochloride Tablets Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Lerociclib Hydrochloride Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Lerociclib Hydrochloride Tablets Manufacturer Market Share in 2025
- 3.4.3 Top 6 Lerociclib Hydrochloride Tablets Manufacturer Market Share in 2025
- 3.5 Lerociclib Hydrochloride Tablets Market: Overall Company Footprint Analysis
- 3.5.1 Lerociclib Hydrochloride Tablets Market: Region Footprint
- 3.5.2 Lerociclib Hydrochloride Tablets Market: Company Product Type Footprint
- 3.5.3 Lerociclib Hydrochloride Tablets Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Lerociclib Hydrochloride Tablets Market Size by Region
- 4.1.1 Global Lerociclib Hydrochloride Tablets Sales Quantity by Region (2021-2032)
- 4.1.2 Global Lerociclib Hydrochloride Tablets Consumption Value by Region (2021-2032)
- 4.1.3 Global Lerociclib Hydrochloride Tablets Average Price by Region (2021-2032)
- 4.2 North America Lerociclib Hydrochloride Tablets Consumption Value (2021-2032)
- 4.3 Europe Lerociclib Hydrochloride Tablets Consumption Value (2021-2032)
- 4.4 Asia-Pacific Lerociclib Hydrochloride Tablets Consumption Value (2021-2032)
- 4.5 South America Lerociclib Hydrochloride Tablets Consumption Value (2021-2032)
- 4.6 Middle East & Africa Lerociclib Hydrochloride Tablets Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Lerociclib Hydrochloride Tablets Sales Quantity by Type (2021-2032)
- 5.2 Global Lerociclib Hydrochloride Tablets Consumption Value by Type (2021-2032)
- 5.3 Global Lerociclib Hydrochloride Tablets Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Lerociclib Hydrochloride Tablets Sales Quantity by Application (2021-2032)
- 6.2 Global Lerociclib Hydrochloride Tablets Consumption Value by Application (2021-2032)
- 6.3 Global Lerociclib Hydrochloride Tablets Average Price by Application (2021-2032)
7 North America
- 7.1 North America Lerociclib Hydrochloride Tablets Sales Quantity by Type (2021-2032)
- 7.2 North America Lerociclib Hydrochloride Tablets Sales Quantity by Application (2021-2032)
- 7.3 North America Lerociclib Hydrochloride Tablets Market Size by Country
- 7.3.1 North America Lerociclib Hydrochloride Tablets Sales Quantity by Country (2021-2032)
- 7.3.2 North America Lerociclib Hydrochloride Tablets Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Lerociclib Hydrochloride Tablets Sales Quantity by Type (2021-2032)
- 8.2 Europe Lerociclib Hydrochloride Tablets Sales Quantity by Application (2021-2032)
- 8.3 Europe Lerociclib Hydrochloride Tablets Market Size by Country
- 8.3.1 Europe Lerociclib Hydrochloride Tablets Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Lerociclib Hydrochloride Tablets Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Lerociclib Hydrochloride Tablets Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Lerociclib Hydrochloride Tablets Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Lerociclib Hydrochloride Tablets Market Size by Region
- 9.3.1 Asia-Pacific Lerociclib Hydrochloride Tablets Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Lerociclib Hydrochloride Tablets Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Lerociclib Hydrochloride Tablets Sales Quantity by Type (2021-2032)
- 10.2 South America Lerociclib Hydrochloride Tablets Sales Quantity by Application (2021-2032)
- 10.3 South America Lerociclib Hydrochloride Tablets Market Size by Country
- 10.3.1 South America Lerociclib Hydrochloride Tablets Sales Quantity by Country (2021-2032)
- 10.3.2 South America Lerociclib Hydrochloride Tablets Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Lerociclib Hydrochloride Tablets Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Lerociclib Hydrochloride Tablets Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Lerociclib Hydrochloride Tablets Market Size by Country
- 11.3.1 Middle East & Africa Lerociclib Hydrochloride Tablets Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Lerociclib Hydrochloride Tablets Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Lerociclib Hydrochloride Tablets Market Drivers
- 12.2 Lerociclib Hydrochloride Tablets Market Restraints
- 12.3 Lerociclib Hydrochloride Tablets Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Lerociclib Hydrochloride Tablets and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Lerociclib Hydrochloride Tablets
- 13.3 Lerociclib Hydrochloride Tablets Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Lerociclib Hydrochloride Tablets Typical Distributors
- 14.3 Lerociclib Hydrochloride Tablets Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Lerociclib Hydrochloride Tablets. Industry analysis & Market Report on Lerociclib Hydrochloride Tablets is a syndicated market report, published as Global Lerociclib Hydrochloride Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Lerociclib Hydrochloride Tablets market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
